differences between fetal and maternal macrophage activation states could potentially drive unique responses to infection and inflammatory stressors. Fetal HBCs also strongly express genes associated with M1 macrophage responses, suggesting more phenotypic diversity than previously described.
OBJECTIVE:
The inflammatory changes in the placenta that are intially associated with uterine quiescence but are later associated with labor and delivery need to be elucidated. During steady state, monocytes differentiate into macrophages that maintain tolerance and homeostasis. In inflammatory states, such as inflammatory bowel disease (IBD), this differentiation is arrested, the monocyte population increases and neutrophils accumulate. Additionally, these monocytes can differentiate into dendritic cells (DCs) capable of migrating into lymph nodes where thay can prime T cells and induce an immune response. We analyzed these alterations in placentas throughout normal pregnancy as compared to those observed in a mouse model of IBD. STUDY DESIGN: We utilized 6-8 week old CX 3 CR 1 -GFP mice (n¼25) in which the CD11b + myeloid cell populations are defined as: CX3CR 1 hi macrophages, CX3CR 1 int pro-inflammatory effector monocytes, and CX3CR 1 neg neutrophils. Under inflammatory conditions, these monocytes can give rise to CCR7-expressing CX 3 CR 1 int Ly6C lo DCs capable of migrating to the lymph nodes. We analyzed these cell populations by flow cytometry in single cell suspensions derived form placentas at designated time points in pregnancy (day 12,16,19) . We compared these results to those observed in colons from and IBD model, in which mice are fed with dextran sulfate sodium salt, that induces severe inflammation. RESULTS: Surprisingly, throughout normal pregnancy a predominant pro-inflammatory effector monocyte population accumulates in the placenta (Figure 1 ). This corrleates to the acute inflammatory phase in IBD. Before labor and delivery the resting macrophage population disappears and an influx of neutrophils is demonstrated. We also detected that before delivery moonocyte derived DCs upregulate the chemokine receptor CCR7 indicating a transition from a "tolerant"-to an "inflammatory" state from midpregnancy to term (Figure 2) . CONCLUSION: The myeloid cell population in the placenta is unique demonstrating a high prepondrance of pro-inflammatory monocytes. This resembles an inflammatory state as observed in IBD and not a steady state. Before labor these monocytes do not differentiate into resting macrophages but rather into inflammatory effector DCs capable of migrtaion into lymph nodes and primng an immune response. These new findings may help shed new light on the cellular mechanisms underlying the sterile inflammation leading to labor and dleivery. low cells) activity as medial CD45 intensity was analyzed by FACS. RESULTS: LPS significantly increased brain nNOS, NFkB, IL-6 & TNF-a protein brain levels in NP & P mice. PRO pretreat ment significantly reduced nNOS and NFkB brain levels following LPS treatment in both groups. In NP mice, LPS treatment significant increased brain IMC population, and PRO pretreatment reduced the increase. In P mice, neither LPS nor LPS & PRO altered the brain IMC population. LPS led to a significant increase in microglial activity both groups. PRO pretreatment led to significant decrease in microglial activity in P mice. In NP mice, there was a trend but it did not reach statistical significance. PRO had no effect on serum IL-6 levels in both groups.
Poster Session V ajog.org CONCLUSION: PRO attenuates the inflammatory response in the brain in NP & P mice but had no effect on systemic (IL-6) inflammation. LPS increased brain IMC population in NP mice but not in P mice and PRO pretreatment reduced the IMC increase. These results suggest that endogenous PRO during pregnancy may protect the brain from LPS-induced central inflammation.
1020 Regulatory effect of various perinatal multipotent stromal cells on T cells.
Ramon Coronado, Shatha Dallo
Lester Smith Medical Research Institute, San Antonio, TX OBJECTIVE: Human Multipotent Stromal Cells (MSCs) have been shown to modulate the maternal immune system, such inhibition of T cell proliferation, interference with B cell function, dendritic cell maturation, and promotion of anti-inflammatory macrophagemediated responses. However, the immune-regulatory effect of perinatal MSCs using different tissue sources has not been directly compared. The objective of this study was to understand the capability of different perinatal tissue MSCs in affecting T cells. Here, we isolated cells from different perinatal tissue (amnion, chorion, Wharton's jelly, and placental.) with phenotypic characteristics typical of MSCs, and studied their paracrine effect on T cells. STUDY DESIGN: Isolated Human Amniotic, Chorion, Placental, and Wharton Jelly MSCs were seeded in 24 well plates. To study the paracrine effect of MSCs on T cells, trans-well inserts were placed in the wells containing the different placenta MSCs in RPMI supplemented with 10% FBS and T cell activator CD2/CD28/CD3. Huma peripheral mononuclear cells (PBMCs) were added in the trans-well inserts containing the above-mentioned media and activator. Plates were placed at 37 C for 4 days and PBMCs were collected. T cells proliferation and T cell regulatory (Tregs) induction were measured by flow cytometry using Cell Tracker and CD4, CD25, and FoxP3, respectively. RESULTS: We report that all human perinatal MSCs inhibited T cell (CD4+) proliferation, albeit at different levels. Similarly, MSCs induced upregulation of Tregs (CD25+FoxP3+) cells at different percentages depending on the MSC tissue source. CONCLUSION: The origin of perinatal MSC has an influence on the capability to inhibit T cell proliferation and the upregulation of Treg in vitro.
